Neuro-Oncology Reviews
Volume
25 Number 7
15 April 2023
Home > Publications > Neuro-Oncology Reviews > Volume 25, Year 2023 > Number 7, 15 April
Rahman R, Polley MC, Alder L,
Brastianos PK, Anders CK, Tawbi HA, Mehta M, Wen PY, Geyer S, de
Groot J, Zadeh G, Piantadosi S, Galanis E, Khasraw M.
Current
drug development and trial designs in neuro-oncology: report from
the first American Society of Clinical Oncology and Society for
Neuro-Oncology Clinical Trials Conference.
Lancet
Oncol. 2023 Apr;24(4):e161-e171∟.
doi: 10.1016/S1470-2045(23)00005-0∟.
PMID: 36990614∟.
Meeting
report˰ ˍ
Cocito C, Martin B, Giantini-Larsen
AM, Valcarce-Aspegren M, Souweidane MM, Szalontay L, Dahmane N,
Greenfield JP.
Leptomeningeal
dissemination in pediatric brain tumors.
Neoplasia.
2023 Apr 1;39:100898∟.
doi: 10.1016/j.neo.2023.100898∟.
PMID: 37011459∟.
Review.
ˍ
Otani Y, Satomi K, Suruga Y, Ishida J, Fujii K, Ichimura K, Date
I.
Utility of genome-wide DNA
methylation profiling for pediatric-type diffuse gliomas.
Brain
Tumor Pathol. 2023 Apr 1∟.
doi: 10.1007/s10014-023-00457-6∟.
PMID: 37004583∟.
Review˰
ˍ
*
Yalamarty SSK, Filipczak N, Li X, Subhan MA, Parveen F, Ataide JA,
Rajmalani BA, Torchilin VP.
Mechanisms
of Resistance and Current Treatment Options for Glioblastoma
Multiforme (GBM).
Cancers
(Basel). 2023 Apr 1;15(7):2116∟.
doi: 10.3390/cancers15072116∟.
PMID: 37046777∟.
Review.
ˍ
Neth BJ, Webb MJ, Parney IF, Sener UT.
The
Current Status, Challenges, and Future Potential of Therapeutic
Vaccination in Glioblastoma.
Pharmaceutics.
2023 Apr 3;15(4):1134∟.
doi: 10.3390/pharmaceutics15041134∟.
PMID: 37111620∟.
Review. ˍ
Alimonti P, Gonzalez Castro LN.
The
Current Landscape of Immune Checkpoint Inhibitor Immunotherapy for
Primary and Metastatic Brain Tumors.
Antibodies
(Basel). 2023 Apr 4;12(2):27∟.
doi: 10.3390/antib12020027∟.
PMID: 37092448∟.
Review. ˍ
Hossain R, Ibrahim RB, Hashim
HB.
Automated
brain tumor detection using machine learning: A bibliometric
review.
World
Neurosurg. 2023 Apr 4;S1878-8750(23)00440-0∟.
doi: 10.1016/j.wneu.2023.03.115∟.
PMID: 37019303∟.
Bibliometric
analysis˰ ˍ
Chartouni A, Mouawad A, Boutros M, Attieh F, Medawar N, Kourie
HR.
Mesenchymal stem cells: a trojan
horse to treat glioblastoma.
Invest
New Drugs. 2023 Apr 5∟.
doi: 10.1007/s10637-023-01352-9∟.
PMID: 37017885∟.
Review˰
ˍ
Bailleul J, Vlashi
E.
Glioblastomas:
Hijacking Metabolism to Build a Flexible Shield for Therapy
Resistance.
Antioxid
Redox Signal. 2023 Apr 5∟.
doi: 10.1089/ars.2022.0088∟.
PMID: 37022791∟.
Review˰
ˍ
McKevitt FM.
What
neurologists can do for neuro-oncology patients.
Pract
Neurol. 2023 Apr 5:pn-2022-003665∟.
doi: 10.1136/pn-2022-003665∟.
PMID: 37019612∟.
Review˰
ˍ
Wu SQ, Liu Y, Zhou J, You YT, Zhou XH, Chen LQ, Kwan HY, Zhao XS,
Wu YF, Liu YY.
Research trends and
prospects on brain metastasis from breast cancer: A bibliometric
analysis.
Front Oncol. 2023 Apr 5;13:1091249∟.
doi: 10.3389/fonc.2023.1091249∟.
PMID: 37091185∟.
Bibliometric analysis. ˍ
*
Agrawal M, Mishra S, Garg K, Ranjan M, Kasper E, Rezai A, Agrawal
D, Singh M, Kale SS.
Trends in
Stereotactic Radiosurgery for Intracranial and Spinal Pathologies:
Analysis of the Top 100 Most Cited Articles.
Neurol
India. 2023 Apr 6;71(Supplement):S39-S48∟.
doi: 10.4103/0028-3886.373651? PMID: 37026333∟.
Bibliometric analysis. ˍ
Akimoto J.
An
enduring debate on gliomatosis cerebri.
Brain
Tumor Pathol. 2023 Apr 6∟.
doi: 10.1007/s10014-023-00454-9∟.
PMID: 37022648∟.
Review˰
ˍ
Garg K, Agrawal D.
Role of Stereotactic
Radiosurgery in Glial Tumors.
Neurol
India. 2023 Apr 6;71(Supplement):S207-S214∟.
doi: 10.4103/0028-3886.373633? PMID: 37026354∟.
Review.
ˍ
Grand S, Nedunchelian M, Charara S, Demaison R, Jean C, Galloux A,
Kastler A, Attye A, Berthet C, Krainik A.
Tumor
or not a tumor: Pitfalls and differential diagnosis in
neuro-oncology.
Rev
Neurol (Paris). 2023 Apr 6:S0035-3787(23)00893-7∟.
doi: 10.1016/j.neurol.2023.03.011∟.
PMID: 37030987∟.
Review˰
ˍ
Noon A, Galban S.
Therapeutic avenues
for targeting treatment challenges of diffuse midline
gliomas.
Neoplasia.
2023 Apr 6;40:100899∟.
doi: 10.1016/j.neo.2023.100899∟.
PMID: 37030112∟.
Review.
ˍ
Sahrizan NSA, Manan HA, Abdul Hamid H, Abdullah JM, Yahya
N.
Functional Alteration in the Brain
Due to Tumour Invasion in Paediatric Patients: A Systematic
Review.
Cancers
(Basel). 2023 Apr 6;15(7):2168∟.
doi: 10.3390/cancers15072168∟.
PMID: 37046828∟.
Review.
ˍ
Santiago-Vicente Y, Castillejos-López MJ, Carmona-Aparicio
L, Coballase-Urrutia E, Velasco-Hidalgo L, Niembro Zúñiga
AM, Zapata-Tarrés M, Espíndola LMT.
Immunotherapy
for Pediatric Gliomas: CAR T Cells Against B7H3: A Review of the
Literature.
CNS Neurol
Disord Drug Targets. 2023 Apr 6∟.
doi: 10.2174/1871527322666230406094257∟.
PMID: 37038673∟.
Review˰
ˍ
Williamson D, Schwalbe EC, Bailey S, Clifford SC.
Timing
is everything: A connection between medulloblastoma prognosis and
fetal cerebellar development.
Neuropathol
Appl Neurobiol. 2023 Apr 6:e12903∟.
doi: 10.1111/nan.12903∟.
PMID: 37021628∟.
Review˰
ˍ
Gould A, Gonzales VAA, Dmello CC,
Saganty R, Lukas RV, Zhang DY, Heimberger AB, Canney M, Carpentier
A, Desseaux C, Bouchoux G, Stupp R, Sonabend AM.
Advances
in Blood-Brain Barrier Disruption to Facilitate Drug Delivery for
Infiltrative Gliomas.
Adv
Oncol. 2023 Apr 7;3(1):77-86∟.
doi: 10.1016/j.yao.2023.01.017∟.
PMID: 37860079∟.
Review. ˍ
*
Castillo SP, Galvez-Cancino F, Liu J, Pollard SM, Quezada SA, Yuan
Y.
The tumour ecology of quiescence:
niches across scales of complexity.
Semin
Cancer Biol. 2023 Apr 8:S1044-579X(23)00062-7∟.
doi: 10.1016/j.semcancer.2023.04.004∟.
PMID: 37037400∟.
Review˰ ˍ
Moreira DC, Lam CG, Bhakta N, Boop FA, Chiang J, Merchant TE,
Rodriguez-Galindo C, Gajjar A, Qaddoumi I.
Tackling
Pediatric Low-Grade Gliomas: A Global Perspective.
JCO
Glob Oncol. 2023 Apr;9:e2300017∟.
doi: 10.1200/GO.23.00017∟.
PMID: 37043711∟.
Commentary. ˍ
Marei HE, Hasan A, Pozzoli G, Cenciarelli C.
Cancer
immunotherapy with immune checkpoint inhibitors (ICIs): potential,
mechanisms of resistance, and strategies for reinvigorating T cell
responsiveness when resistance is acquired.
Cancer
Cell Int. 2023 Apr 10;23(1):64∟.
doi: 10.1186/s12935-023-02902-0∟.
PMID: 37038154∟.
Review.
ˍ
Thoidingjam S, Sriramulu S, Freytag S, Brown SL, Kim JH, Chetty
IJ, Siddiqui F, Movsas B, Nyati S.
Oncolytic
virus-based suicide gene therapy for cancer treatment: a
perspective of the clinical trials conducted at Henry Ford
Health.
Transl Med
Commun. 2023 Apr 10;8(1):11∟.
doi: 10.1186/s41231-023-00144-w∟.
PMID: 37065938∟.
Review. ˍ
Eatmann AI, Hamouda E, Hamouda H, Farouk HK, Jobran AWM, Omar AA,
Madeeh AK, Al-Dardery NM, Elnoamany S, Abd-Elnasser EG, Koraiem
AM, Ahmed AA, Abouzid M, Karaźniewicz-Łada M.
Potential
Use of Thalidomide in Glioblastoma Treatment: An Updated Brief
Overview.
Metabolites.
2023 Apr 11;13(4):543∟.
doi: 10.3390/metabo13040543∟.
PMID: 37110201∟.
Review. ˍ
Girotto AL, Gago G, Paglioli Ferreira M.
Remote
hemorrhagic complications of glioma surgery: Systematic review of
the literature and report of a case of distant wounded glioma
syndrome, a rare neurosurgical complication.
World
Neurosurg. 2023 Apr 11:S1878-8750(23)00487-4∟.
doi: 10.1016/j.wneu.2023.04.013∟.
PMID: 37054950∟.
Case report, Review˰ ˍ
Gupta T, Sahoo RK, Singh H, Katke S, Chaurasiya A, Gupta
U.
Lipid-Based Nanocarriers in the
Treatment of Glioblastoma Multiforme (GBM): Challenges and
Opportunities.
AAPS
PharmSciTech. 2023 Apr 11;24(4):102∟.
doi: 10.1208/s12249-023-02555-2∟.
PMID: 37041350∟.
Review˰ ˍ
Lorrey SJ, Waibl Polania J, Wachsmuth LP, Hoyt-Miggelbrink A,
Tritz ZP, Edwards R, Wolf DM, Johnson AJ, Fecci PE, Ayasoufi
K.
Systemic immune derangements are
shared across various CNS pathologies and reflect novel mechanisms
of immune privilege.
Neurooncol
Adv. 2023 Apr 11;5(1):vdad035∟.
doi: 10.1093/noajnl/vdad035∟.
PMID: 37207119∟.
Review. ˍ
Park CK, Chang JH.
Korean Brain Tumor
Society (KBTS) Consensus Review for the Practical Recommendations
on Glioma Management in Korea.
J
Korean Neurosurg Soc. 2023 Apr 11∟.
doi: 10.3340/jkns.2023.0046∟.
PMID: 37042171∟.
Guidelines. ˍ
Jovanovich N, Habib A, Head J, Hameed F, Agnihotri S, Zinn
PO.
Pediatric diffuse midline glioma:
Understanding the mechanisms and assessing the next generation of
personalized therapeutics.
Neurooncol
Adv. 2023 Apr 12;5(1):vdad040∟.
doi: 10.1093/noajnl/vdad040∟.
PMID: 37152806∟.
Review. ˍ
Niyazi M, Andratschke N, Bendszus M, Chalmers AJ, Erridge SC,
Galldiks N, Lagerwaard FJ, Navarria P, Munck Af Rosenschöld
P, Ricardi U, van den Bent MJ, Weller M, Belka C, Minniti
G.
ESTRO-EANO guideline on target
delineation and radiotherapy details for glioblastoma.
Radiother
Oncol. 2023 Apr 12:109663∟.
doi: 10.1016/j.radonc.2023.109663∟.
PMID: 37059335∟.
Guidelines. ˍ
*
Zhao B, Wu J, Li H, Wang Y, Wang Y, Xing H, Wang Y, Ma W.
Recent
advances and future challenges of tumor vaccination therapy for
recurrent glioblastoma.
Cell
Commun Signal. 2023 Apr 12;21(1):74∟.
doi: 10.1186/s12964-023-01098-0∟.
PMID: 37046332∟.
Review. ˍ
Galldiks N, Lohmann P, Fink GR, Langen KJ.
Amino
Acid PET in Neurooncology.
J
Nucl Med. 2023 Apr 13:264859∟.
doi: 10.2967/jnumed.122.264859∟.
PMID: 37055222∟.
Continuing education. ˍ
Gállego Pérez-Larraya J, García-Moure M,
Alonso MM.
Oncolytic virotherapy for
the treatment of pediatric brainstem gliomas.
Rev
Neurol (Paris). 2023 Apr 13:S0035-3787(23)00897-4∟.
doi: 10.1016/j.neurol.2023.03.016∟.
PMID: 37061388∟.
Review˰ ˍ
Jellema PEJ, Wijnen JP, De Luca A, Mutsaerts HJMM, Obdeijn IV, van
Baarsen KM, Lequin MH, Hoving EW.
Advanced
intraoperative MRI in pediatric brain tumor surgery.
Front
Physiol. 2023 Apr 13;14:1098959∟.
doi: 10.3389/fphys.2023.1098959∟.
PMID: 37123260∟.
Review. ˍ
*
Sendy F, Arrighi M, Berton Q, Mourinet S, Screnci M, Gallot D,
Coll G.
Diagnosis of medulloblastoma in
pregnant women: to continue with the pregnancy or not? A case
report and literature review.
Neurochirurgie.
2023 Apr 13:101443∟.
doi: 10.1016/j.neuchi.2023.101443∟.
PMID: 37061180∟.
Case report, Review˰ ˍ
Ahmed MH, Canney M, Carpentier A, Idbaih A.
Overcoming
the blood brain barrier in glioblastoma: Status and future
perspective.
Rev Neurol
(Paris). 2023 Apr 14:S0035-3787(23)00895-0∟.
doi: 10.1016/j.neurol.2023.03.013∟.
PMID: 37062676∟.
Review˰ ˍ
Trinder SM, McKay C, Power P, Topp M, Chan B, Valvi S, McCowage G,
Govender D, Kirby M, Ziegler DS, Manoharan N, Hassall T, Kellie S,
Heath J, Alvaro F, Wood P, Laughton S, Tsui K, Dodgshun A,
Eisenstat DD, Endersby R, Luen SJ, Koh ES, Sim HW, Kong B,
Gottardo NG, Whittle JR, Khuong-Quang DA, Hansford
JR.
BRAF-mediated brain tumors in
adults and children: A review and the Australian and New Zealand
experience.
Front
Oncol. 2023 Apr 14;13:1154246∟.
doi: 10.3389/fonc.2023.1154246∟.
PMID: 37124503∟.
Review. ˍ
Zeng YF, Wei XY, Guo QH, Chen SY, Deng S, Liu ZZ, Gong ZC, Zeng
WJ.
The efficacy and safety of
anti-PD-1/PD-L1 in treatment of glioma: a single-arm
meta-analysis.
Front
Immunol. 2023 Apr 14;14:1168244∟.
doi: 10.3389/fimmu.2023.1168244∟.
PMID: 37122727∟.
Meta-analysis. ˍ
Alshiekh Nasany R, de la Fuente MI.
Therapies
for IDH-Mutant Gliomas.
Curr
Neurol Neurosci Rep. 2023 Apr 15∟.
doi: 10.1007/s11910-023-01265-3∟.
PMID: 37060388∟.
Review. ˍ